Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo
1999
Collagen Changes in Ovarian Tumors
publication
Author Information
Author(s): Kauppila S, Bode M K, Stenbäck F, Risteli L, Risteli J
Primary Institution: University of Oulu
Hypothesis
The study aims to characterize collagen cross-linking in human ovarian carcinoma tissue in vivo.
Conclusion
The study found that collagen cross-linking is defective in malignant ovarian tumors compared to benign ones.
Supporting Evidence
- Malignant samples had about 20% of the total collagen compared to benign tumors.
- Cross-linked telopeptide antigens in malignant tumors were smaller and more heterogeneous.
- Immunostaining showed disorganized collagen bundles in carcinomas.
Takeaway
In cancerous ovarian tumors, the collagen that helps hold tissues together is not working properly, which might make the tumors easier to invade other tissues.
Methodology
Biochemical and immunochemical methods were used to analyze collagen in benign and malignant serous tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website